Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. - Romond,E.H.; Perez,E.A.; Bryant,J..; Suman,V.J.; Geyer,C.E.; Davidson,N.E.; et,al.. (N Engl J Med, 2005)